+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
Mephentermine (CAS 100-92-5) Global Market Research Report 2024 - Product Thumbnail Image

Mephentermine (CAS 100-92-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Labetalol (CAS 36894-69-6) Global Market Research Report 2024 - Product Thumbnail Image

Labetalol (CAS 36894-69-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Indecainide (CAS 74517-78-5) Global Market Research Report 2024 - Product Thumbnail Image

Indecainide (CAS 74517-78-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Ivabradine (CAS 155974-00-8) Global Market Research Report 2024 - Product Thumbnail Image

Ivabradine (CAS 155974-00-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Hydralazine (CAS 86-54-4) Global Market Research Report 2024 - Product Thumbnail Image

Hydralazine (CAS 86-54-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Irbesartan (CAS 138402-11-6) Global Market Research Report 2024 - Product Thumbnail Image

Irbesartan (CAS 138402-11-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Fenofibrate (CAS 49562-28-9) Global Market Research Report 2024 - Product Thumbnail Image

Fenofibrate (CAS 49562-28-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Fosinopril (CAS 98048-97-6) Global Market Research Report 2024 - Product Thumbnail Image

Fosinopril (CAS 98048-97-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Guanfacine (CAS 29110-47-2) Global Market Research Report 2024 - Product Thumbnail Image

Guanfacine (CAS 29110-47-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Gemfibrozil (CAS 25812-30-0) Global Market Research Report 2024 - Product Thumbnail Image

Gemfibrozil (CAS 25812-30-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Gemcabene (CAS 183293-82-5) Global Market Research Report 2024 - Product Thumbnail Image

Gemcabene (CAS 183293-82-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more